Literature DB >> 158452

Genetic control of suppressor lymphocyte function in myasthenia gravis: relationship of impaired suppressor function to HLA-B8/DRW3 and cold reactive lymphocytotoxic antibodies.

P J Zilko, R L Dawkins, K Holmes, C Witt.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 158452     DOI: 10.1016/0090-1229(79)90143-0

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


× No keyword cloud information.
  13 in total

Review 1.  Immunopathogenesis and treatment of myasthenia gravis.

Authors:  A I Levinson; B Zweiman; R P Lisak
Journal:  J Clin Immunol       Date:  1987-05       Impact factor: 8.317

2.  Rearrangement of 21-hydroxylase genes in disease-associated MHC supratypes.

Authors:  M J Garlepp; A N Wilton; R L Dawkins; P C White
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

3.  Autoimmune disorders--analysis by study of T cells, implications and speculations.

Authors:  M Feldmann; M Londei; P de Berardinis; G Essery; C Greenall; B Grubeck-Loebenstein; J Knight; Z Leech; A Kingsbury; R N Maini
Journal:  Agents Actions       Date:  1986-12

Review 4.  Phenotypic and functional analysis of lymphocytes in myasthenia gravis.

Authors:  A I Levinson; R P Lisak; B Zweiman; M Kornstein
Journal:  Springer Semin Immunopathol       Date:  1985

Review 5.  The use of concanavalin A to study the immunoregulation of human T cells.

Authors:  J M Dwyer; C Johnson
Journal:  Clin Exp Immunol       Date:  1981-11       Impact factor: 4.330

6.  Glycaemic control and suppressor cell activity in patients with insulin-dependent diabetes mellitus.

Authors:  K Buschard; S Madsbad; T Krarup; J Rygaard
Journal:  Clin Exp Immunol       Date:  1982-04       Impact factor: 4.330

7.  Immune regulation in inflammatory bowel disease: absence of a serum inhibitor of suppressor cell function.

Authors:  B J Kemler; E Alpert
Journal:  Clin Exp Immunol       Date:  1980-11       Impact factor: 4.330

8.  Increased sensitivity to concanavalin A and a suppressor cell defect in chronic active hepatitis.

Authors:  C de Galocsy; P J Jenkins; G Mieli-Vergani; A L Eddleston; R Williams
Journal:  Clin Exp Immunol       Date:  1981-03       Impact factor: 4.330

9.  Lymphocytotoxins in rheumatoid arthritis: prevalence, lymphocyte specificity, and HLA-DR antigens.

Authors:  P H Wooley; G S Panayi; J R Batchelor
Journal:  Ann Rheum Dis       Date:  1981-04       Impact factor: 19.103

10.  Primary immunoglobulin deficiency and haematological disorders.

Authors:  M A French; R L Dawkins; J M Jackson
Journal:  Postgrad Med J       Date:  1983-05       Impact factor: 2.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.